Alzamend Neuro (ALZN) Insider Trading & Ownership $0.96 -0.06 (-6.12%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.94 -0.01 (-1.32%) As of 02/21/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Alzamend Neuro (NASDAQ:ALZN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.55%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1,290.05Number OfInsiders Selling(Last 12 Months)0 Get ALZN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALZN Insider Buying and Selling by Quarter Alzamend Neuro Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/6/2024Milton C Ault IIIDirectorBuy75$2.75$206.25 7/31/2024Milton C Ault IIIDirectorBuy25$3.74$93.50 4/19/2024Milton C Ault IIIDirectorBuy100$6.90$690.00 4/1/2024Milton C Ault IIIDirectorBuy33$9.10$300.30 (Data available from 1/1/2013 forward) ALZN Insider Trading Activity - Frequently Asked Questions Who is on Alzamend Neuro's Insider Roster? The list of insiders at Alzamend Neuro includes David J Katzoff, Lynne Fahey Mcgrath, Mark Gustafson, Milton C Ault III, and Stephan Jackman. Learn more on insiders at ALZN. What percentage of Alzamend Neuro stock is owned by insiders? 10.55% of Alzamend Neuro stock is owned by insiders. Learn more on ALZN's insider holdings. Which Alzamend Neuro insiders have been buying company stock? The following insiders have purchased ALZN shares in the last 24 months: David J Katzoff ($10,060.50), Lynne Fahey Mcgrath ($4,257.00), Milton C Ault III ($19,594.05), and Stephan Jackman ($19,926.00). How much insider buying is happening at Alzamend Neuro? Insiders have purchased a total of 1,614 ALZN shares in the last 24 months for a total of $53,837.55 bought. Alzamend Neuro Key ExecutivesMr. Stephan Jackman (Age 47)CEO & Director Compensation: $434.24kMr. David J. Katzoff (Age 61)Chief Financial Officer Compensation: $116.67kMr. Milton Charles Ault III (Age 54)Founder & Vice Chairman Mr. Henry C. W. Nisser Esq. (Age 55)Executive VP, General Counsel & Director Compensation: $50kMr. Kenneth S. Cragun CPA (Age 63)Senior Vice President of Finance More Insider Trading Tools from MarketBeat Related Companies BioAtla Insider Trading Tonix Pharmaceuticals Insider Trading Mannatech Insider Trading 60 Degrees Pharmaceuticals Insider Trading IN8bio Insider Trading Senti Biosciences Insider Trading LianBio Insider Trading Lipocine Insider Trading Aprea Therapeutics Insider Trading MIRA Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:ALZN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
